Synthesis, In Silico Study and Antibacterial Evaluation of New Cyanopyridine Based Scaffold

References

• Jose M. Munita, and CESAR A. Arias, “Mechanisms of Antibiotic Resistance,” Microbiology Spectrum 4, no. 2 (2016).doi: 10.1128/microbiolspec.VMBF-0016-2015.
   PubMed Web of Science ®Google Scholar
• David J. Payne, Michael N. Gwynn, David J. Holmes, and David L. Pompliano, “Drugs for Bad Bugs: Confronting the Challenges of Antibacterial Discovery,” Nature Reviews Drug Discovery 6, no. 1 (2007): 29–40.
   PubMed Web of Science ®Google Scholar
• R. Jayaraman, “Antibiotic Resistance, Anoverview of Mechanisms and a Paradigm Shift,” Current Science 96, no. 11 (2009): 1475–84.
   Web of Science ®Google Scholar
• anna-pelagia Magiorakos, A. Srinivasan, Roberta B Carey, Yehuda Carmeli, M. E. Falagas, C. G. Giske, S. Harbarth, J. F. Hindler, Gunnar Kahlmeter, Barbro Olsson-Liljequist, et al. “Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Bacteria: An International Expert Proposal for Interim Standard Definitions for Acquired Resistance,” Clinical Microbiology and Infection 18, no. 3 (2012): 268–81.
   PubMed Web of Science ®Google Scholar
• Francesca. Prestinaci, Patrizio. Pezzotti, and Annalisa. Pantosti, “Antimicrobial Resistance: A Global Multifaceted Phenomenon,” Pathogens and Global Health 109, no. 7 (2015): 309–18.
   PubMed Web of Science ®Google Scholar
• James A. Ayukekbong, Michel. Ntemgwa, and Andrew N. Atabe, “The Threat of Antimicrobial Resistance in Developing Countries: Causes and Control Strategies,” Antimicrobial Resistance and Infection Control 6, (2017): 47.
   PubMed Web of Science ®Google Scholar
• Sameer. Dhingra, Nor Azlina A. Rahman, Ed. Peile, Motiur. Rahman, Massimo. Sartelli, Mohamed Azmi. Hassali, Tariqul. Islam, Salequl. Islam, and Mainul. Haque, “Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter,” Frontiers in Public Health 8, (2020): 535668.
   PubMed Web of Science ®Google Scholar
• Ali Al. Bshabshe, Martin R. P. Joseph, Amgad A. Awad El-Gied, Abdalla N. Fadul, Harish C. Chandramoorthy, and Mohamed E. Hamid, “Clinical Relevance and Antimicrobial Profiling of Methicillin-Resistant Staphylococcus aureus (MRSA) on Routine Antibiotics and Ethanol Extract of Mango Kernel (Mangifera indica L.),” BioMed Research International 2020, (2020): 4150678.
   PubMed Web of Science ®Google Scholar
• Jessica L. Lister, and Alexander R. Horswil, “Staphylococcus aureus Biofilms: Recent Developments in Biofilm Dispersal,” Frontiers in Cellular and Infection Microbiology 4, (2014): 178.
   PubMed Web of Science ®Google Scholar
• Steven Y. C. Tong, Joshua S. Davis, Emily. Eichenberger, Thomas L. Holland, and Vance G. Fowler, Jr, “Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management,” Clinical Microbiology Reviews 28, no. 3 (2015): 603–61.
   PubMed Web of Science ®Google Scholar
• Masoud. Dadashi, Mohammad Javad. Nasiri, Fatemeh. Fallah, Parviz. Owlia, Bahareh. Hajikhani, Mohammad. Emaneini, and Mirsasan. Mirpour, “Methicillin-Resistant Staphylococcus aureus (MRSA) in Iran: A Systematic Review and Meta-Analysis,” Journal of Global Antimicrobial Resistance 12, (2018): 96–103.
   PubMed Web of Science ®Google Scholar
• Julia. Drebes, Madeleine. Kunz, Claudio A. Pereira, Christian. Betzel, and Carsten. Wrenger, “MRSA Infections: From Classical Treatment to Suicide Drugs,” Current Medicinal Chemistry 21, no. 15 (2014): 1809–19.
   PubMed Web of Science ®Google Scholar
• Andrew J. Stewardson, Arthur. Alligno, Jan. Beyersmann, Nicholas. Graves, Martin. Schumacher, Rodolphe. Meyer, Evelina. Tacconelli, Giulia. De Angelis, Claudio. Farina, Fabio. Pezzoli, et al. “The Health and Economic Burden of Bloodstream Infections Caused by Antimicrobial-Susceptible and Non-Susceptible Enterobacteriaceae and Staphylococcus aureus in European Hospitals, 2010 and 2011: A Multicentre Retrospective Cohort Study,” Eurosurveillance 21, no. 33 (2016): 30319–30.
   Web of Science ®Google Scholar
• E. Tchouaket Nguemeleu, I. Beogo, D. Sia, K. Kilpatrick, C. Séguin, A. Baillot, M. Jabbour, N. Parisien, S. Robins, and S. Boivin, “Economic Analysis of Healthcare-Associated Infection Prevention and Control Interventions in Medical and Surgical Units: Systematic Review Using a Discounting Approach,” The Journal of Hospital Infection 106, no. 1 (2020): 134–54.
   PubMed Web of Science ®Google Scholar
• Setegn. Eshetie, Fentahun. Tarekegn, Feleke. Moges, Anteneh. Amsalu, Wubet. Birhan, and Kahsay. Huruy, “Methicillin Resistant Staphylococcus aureus in Ethiopia: A Meta-Analysis,” BMC Infectious Diseases 16, no. 1 (2016): 689–97.
   PubMedGoogle Scholar
• Bhawna. Malik, and Samit. Bhattacharyya, “Antibiotic Drug-Resistance as a Complex System Driven by Socio-Economic Growth and Antibiotic Misuse,” Scientific Reports 9, no. 1 (2019): 15184.
   PubMedGoogle Scholar
• Elisa. Andreozzi, and Gaylen A. Uhlich, “PchE Regulation of Escherichia coli O157:H7 Flagella, Controlling the Transition to Host Cell Attachment,” International Journal of Molecular Sciences 21, no. 13 (2020): 4592–607.
   PubMed Web of Science ®Google Scholar
• Shengliang. Liao, Shibin. Shang, Minggui. Shen, Xiaoping. Rao, Hongyan. Si, Jie. Song, and Zhanqian. Song, “One-Pot Synthesis and Antimicrobial Evaluation of Novel 3-Cyanopyridine Derivatives of (-)-β-Pinene,” Bioorganic & Medicinal Chemistry Letters 26, no. 6 (2016): 1512–5.
   PubMed Web of Science ®Google Scholar
• Dipen H. Vyas, Satishkumar D. Tala, Jaber. Akbari, Manoj F. Dhaduk, Kaushik A. Joshi, and Hitendra. Joshi, “Synthesis and Antimicrobial Activity of New Cyanopyridine and Cyanopyrans towards Mycobacterium tuberculosis and Other Microorganisms,” Indian Journal of Chemistry Section B 48, (2009): 833–9.
   Web of Science ®Google Scholar
• V. R. Dangar, K. N. Borkhataria, and V. R. Shah, “Synthesis, Characterization and Antimicrobial Activity of Cyanopyridine Derivatives with Vanillin,” International Journal of Pharma Sciences and Research 5, no. 2 (2014): 20–4.
   Google Scholar
• Srinivasa Rao. Atla, Neelakanta Rao. Nagireddy, and Rajendra Prasad. Yejella, “Anti-Inflammatory, Analgesic and Antimicrobial Activity Studies of Novel 4, 6-Disubstituted-2-Amino-3- Cyanopyridines,” International Journal of Pharmaceutical Chemistry and Analysis 1, no. 1 (2014): 57–47.
   Google Scholar
• Hassan M. Faidallah, Sherif A. F. Rostom, Abdullah M. Asiri, Khalid A. Khan, Mohammed F. Radwan, and Hani Z. Asfour, “3-Cyano-8-Methyl-2-Oxo-1,4-Disubstituted-1,2,5,6,7,8-Hexahydroquinolines: Synthesis and Biological Evaluation as Antimicrobial and Cytotoxic Agents,” Journal of Enzyme Inhibition and Medicinal Chemistry 28, no. 1 (2013): 123–30.
   PubMed Web of Science ®Google Scholar
• Taslimahemad T. Khatri, and Viresh H. Shah, “One Pot Synthesis of Novel Cyanopyridones as an Intermediate of Bioactive Pyrido[2,3-d]Pyrimidines,” Journal of the Korean Chemical Society 58, no. 4 (2014): 366–76.
   Google Scholar
• Asmaa Kamal. Mourad, Fathia Korany. Mohamed, and Ahmed Yousef. Soliman, “Facile Synthesis of Novel Heterocyclic Compounds with Anticipated Antibacterial Activities Based on Coumarin Moiety,” Heterocycles 96, no. 1 (2018): 50–66.
   Web of Science ®Google Scholar
• Esther Moreno, Daniel Plano, Iranzu Lamberto, María Font, Ignacio Encio, Juan Antonio Palop, and Carmen Sanmartin, “Sulfur and Selenium Derivatives of Quinazoline and Pyrido[2,3-d]Pyrimidine: Synthesis and Study of Their Potential Cytotoxic Activity in Vitro,” European Journal of Medicinal Chemistry 47, (2012): 283–98.
   PubMed Web of Science ®Google Scholar
• Carmen Sanmartin, Mikel Echeverria, Beatriz Mendivil, Lucía Cordeu, Elena Cubedo, Jesús Garcia-Foncillas, María Font, and Juan Antonio Palop, “Synthesis and Biological Evaluation of New Symmetrical Derivatives as Cytotoxic Agents and Apoptosis Inducers,” Bioorganic & Medicinal Chemistry 13, no. 6 (2005): 2031–44.
   PubMed Web of Science ®Google Scholar
• Magda M. F. Ismail, Amel M. Farrag, and Dalal. Abou-Elela, “Synthesis, Anticancer Screening, and in Silico ADME Prediction of Novel 2-Pyridones as Pim Inhibitors,” Journal of Heterocyclic Chemistry 57, (2020): 3442–60.
   Web of Science ®Google Scholar
• Magda M. F. Ismail, and Eman. Noaman, “Novel Pirfenidone Analogs as Antifibrotic Agents, “Synthesis and Antifibrotic Evaluation of 2-Pyridones and Fused Pyridones,” Medicinal Chemistry Research 14, no. 7 (2005): 382–403.
   Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, M07Ed11, 11th ed. (Wayne, PA: Clinical and Laboratory Standards Institute, 2018).
   Google Scholar
• Maria Dzieduszycka, Maria M. Bontemps-Gracz, Barbara Stefańska, Sante Martelli, Agnieszka Piwkowska, Małgorzata Arciemiuk, and Edward Borowski, “Synthesis of 7-Oxo-7H-Naphtho[1,2,3-de]Quinoline Derivatives as Potential Anticancer Agents Active on Multidrug Resistant Cell Lines,” Bioorganic & Medicinal Chemistry 14, no. 9 (2006): 2880–6.
   PubMed Web of Science ®Google Scholar
• Yousry A. Ammar, Magda M. F. Ismail, Hend M. El-Sehrawi, Eman. Noaman, Ashraf H. Bayomi, and Taghreed Z. Shawer, “Novel Pirfenidone Analogues: Synthesis of Pyridin-2-Ones for the Treatment of Pulmonary Fibrosis,” Archiv Der Pharmazie 339, no. 8 (2006): 429–36.
   PubMed Web of Science ®Google Scholar
• Magda El-Sherbeny, Khairia Youssef, F. S. Al-Shafeih, and A. M. A. Al-Obaid, “Novel Pyridothienopyrimidine and Pyridothienothiazine Derivatives as Potential Antiviral and Antitumour Agents,” Medicinal Chemistry Research 10, (2000): 122–35.
   Web of Science ®Google Scholar
• Antoine. Daina, Olivier. Michielin, and Vincent. Zoete, “SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules,” Scientific Reports 7, (2017): 1–13.
   PubMed Web of Science ®Google Scholar
• Yuan H. Zhao, Michael H. Abraham, Joelle. Le, Anne. Hersey, Chris N. Luscombe, Gordon. Beck, Brad. Sherborne, and Ian. Cooper, “Rate-Limited Steps of Human Oral Absorption and QSAR Studies,” Pharmaceutical Research 19, no. 10 (2002): 1446–57.
   PubMed Web of Science ®Google Scholar
• Douglas E. V. Pires, Tom L. Blundell, and David B. Ascher, “pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures,” Journal of Medicinal Chemistry 58, no. 9 (2015): 4066–72.
   PubMed Web of Science ®Google Scholar
• Neeraj. Kumar, Ravi. Tomar, Apurva. Pandey, Vartika. Tomar, Vimal Kishor. Singh, and Rames. Chandra, “Preclinical Evaluation and Molecular Docking of 1,3-Benzodioxole Propargyl Ether Derivatives as Novel Inhibitor for Combating the Histone Deacetylase Enzyme in Cancer,” Artificial Cells, Nanomedicine, and Biotechnology 46, no. 6 (2018): 1288–99.
   PubMed Web of Science ®Google Scholar